Ledning
Thomas Warthoe
CEO, MEDGRUNDARE
Aktier: 1 521 053
Teckningsoptioner serie TO2: 14 000
Entreprenör med över 20 års erfarenhet av healthcare-industrin (och specifikt diagnostik). Thomas har grundat och drivit tre biotech företag. I två av företagen Thomas grundade, Display System Biotech och Ampligon, gjordes framgångsrika exits. Han har med framgång ingått strategiska partnerskap och licensavtal med globala diag¬nostikföretag såsom Backman Coulter, Shionogi Co och Omron Healthcare under åren. Styrelseledamot i Chip Diagnostics, UPENN, Philadelphia.
Anställd i Qlife Aps sedan grundandet 2018
Maiken Worsøe Rosenstierne
DIRECTOR R&D
Personaloptioner: 30 000
Maiken is a Biochemist with an MSc and PhD Career: Postdoc at University of Copenhagen and at Roskilde University. Maiken was previously a Senior Scientist at Statens Serum Institut and is a respected scientist and a solid leader of multiple R&D projects and our large R&D department.
Kristina Christensen
DIRECTOR QA/RA
Kristina has extensive experience in IVD and Medical Devices within the areas of Quality Assurance, Design Control, Risk Management, Product Development of reagents and instruments and clinical evaluations.
Kasper Boel Rousøe
CFO
Antal aktier: 28 500
Warrant series TO2: 28 500
Personaloptioner: 120 000
Kasper joined Qlife on March 1, 2022, bringing more than 20 years of experience from leading roles in the financial area. Kasper hold a M. Sc. in Economics from Copenhagen University and an EMBA from IMD in Lausanne, Switzerland.